These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 15751092
1. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma. Chen M, Dittmann A, Kuhn A, Ruzicka T, von Mikecz A. Arthritis Rheum; 2005 Mar; 52(3):877-84. PubMed ID: 15751092 [Abstract] [Full Text] [Related]
2. Xenobiotic-induced recruitment of autoantigens to nuclear proteasomes suggests a role for altered antigen processing in scleroderma. Chen M, von Mikecz A. Ann N Y Acad Sci; 2005 Jun; 1051():382-9. PubMed ID: 16126980 [Abstract] [Full Text] [Related]
3. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis. Hénault J, Tremblay M, Clément I, Raymond Y, Senécal JL. Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238 [Abstract] [Full Text] [Related]
4. DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients. Hénault J, Robitaille G, Senécal JL, Raymond Y. Arthritis Rheum; 2006 Mar; 54(3):963-73. PubMed ID: 16508979 [Abstract] [Full Text] [Related]
5. Anti-topoisomerase I autoantibodies in systemic sclerosis. Czömpöly T, Simon D, Czirják L, Németh P. Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194 [Abstract] [Full Text] [Related]
6. Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis. Kim D, Peck A, Santer D, Patole P, Schwartz SM, Molitor JA, Arnett FC, Elkon KB. Arthritis Rheum; 2008 Jul; 58(7):2163-73. PubMed ID: 18576347 [Abstract] [Full Text] [Related]
8. Xenobiotic-induced autoimmunity and protein aggregation diseases share a common subnuclear pathology. von Mikecz A. Autoimmun Rev; 2005 Apr; 4(4):214-8. PubMed ID: 15893714 [Abstract] [Full Text] [Related]
10. Evaluation of topoisomerase-1-specific CD8+ T-cell response in systemic sclerosis. Boin F, Wigley FM, Schneck JP, Oelke M, Rosen A. Ann N Y Acad Sci; 2005 Dec; 1062():137-45. PubMed ID: 16461796 [Abstract] [Full Text] [Related]
12. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera. Kuwana M, Kaburaki J, Medsger TA, Wright TM. Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110 [Abstract] [Full Text] [Related]
13. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma. Henry PA, Atamas SP, Yurovsky VV, Luzina I, Wigley FM, White B. Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031 [Abstract] [Full Text] [Related]
14. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. Kuwana M, Medsger TA, Wright TM. J Immunol; 1995 Sep 01; 155(5):2703-14. PubMed ID: 7650398 [Abstract] [Full Text] [Related]
15. T cell lines from systemic sclerosis patients and healthy controls recognize multiple epitopes on DNA topoisomerase I. Hu PQ, Oppenheim JJ, Medsger TA, Wright TM. J Autoimmun; 2006 Jun 01; 26(4):258-67. PubMed ID: 16735104 [Abstract] [Full Text] [Related]
16. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives. Harvey G, Black C, Maddison P, McHugh N. J Rheumatol; 1997 Mar 01; 24(3):477-84. PubMed ID: 9058652 [Abstract] [Full Text] [Related]
17. Subcellular recruitment of fibrillarin to nucleoplasmic proteasomes: implications for processing of a nucleolar autoantigen. Chen M, Rockel T, Steinweger G, Hemmerich P, Risch J, von Mikecz A. Mol Biol Cell; 2002 Oct 01; 13(10):3576-87. PubMed ID: 12388758 [Abstract] [Full Text] [Related]
18. Involvement of lysosomal cathepsins in the cleavage of DNA topoisomerase I during necrotic cell death. Pacheco FJ, Servin J, Dang D, Kim J, Molinaro C, Daniels T, Brown-Bryan TA, Imoto-Egami M, Casiano CA. Arthritis Rheum; 2005 Jul 01; 52(7):2133-45. PubMed ID: 15986368 [Abstract] [Full Text] [Related]
19. Heparin inhibits the interaction of DNA topoisomerase I/anti-topoisomerase I immune complexes with heparan sulfate on dermal fibroblasts. Arcand J, Robitaille G, Koenig M, Senécal JL, Raymond Y. Arthritis Rheum; 2012 May 01; 64(5):1632-41. PubMed ID: 22095242 [Abstract] [Full Text] [Related]
20. The expression and localization of Scl-70/DNA topoisomerase I vary throughout the cell cycle. Ramirez-Santoyo R, Lopez-Swiderski A, Avalos-Diaz E, Herrera-Esparza R. Rev Rhum Engl Ed; 1998 Mar 01; 65(3):165-72. PubMed ID: 9574473 [Abstract] [Full Text] [Related] Page: [Next] [New Search]